Bank of Montreal Can Has $120,000 Stock Holdings in Balchem Co. (NASDAQ:BCPC)

Bank of Montreal Can cut its holdings in Balchem Co. (NASDAQ:BCPC) by 32.8% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,295 shares of the basic materials company’s stock after selling 631 shares during the quarter. Bank of Montreal Can’s holdings in Balchem were worth $120,000 at the end of the most recent quarter.

Several other large investors have also recently added to or reduced their stakes in BCPC. Cardinal Capital Management raised its holdings in Balchem by 0.8% during the 1st quarter. Cardinal Capital Management now owns 19,132 shares of the basic materials company’s stock worth $1,775,000 after purchasing an additional 151 shares during the last quarter. Thrivent Financial for Lutherans increased its stake in Balchem by 10.9% during the 4th quarter. Thrivent Financial for Lutherans now owns 164,089 shares of the basic materials company’s stock worth $12,856,000 after purchasing an additional 16,099 shares in the last quarter. Bessemer Group Inc. increased its stake in Balchem by 22.7% during the 4th quarter. Bessemer Group Inc. now owns 28,600 shares of the basic materials company’s stock worth $2,241,000 after purchasing an additional 5,300 shares in the last quarter. State of Tennessee Treasury Department increased its stake in Balchem by 1.5% during the 4th quarter. State of Tennessee Treasury Department now owns 53,630 shares of the basic materials company’s stock worth $4,202,000 after purchasing an additional 785 shares in the last quarter. Finally, Metropolitan Life Insurance Co. NY increased its stake in Balchem by 366.6% during the 4th quarter. Metropolitan Life Insurance Co. NY now owns 10,434 shares of the basic materials company’s stock worth $818,000 after purchasing an additional 8,198 shares in the last quarter. 87.00% of the stock is currently owned by institutional investors.

BCPC traded up $0.66 during trading hours on Friday, reaching $99.97. The company’s stock had a trading volume of 369,800 shares, compared to its average volume of 117,481. Balchem Co. has a 52 week low of $73.16 and a 52 week high of $117.79. The company’s 50-day simple moving average is $96.34. The company has a current ratio of 3.47, a quick ratio of 2.43 and a debt-to-equity ratio of 0.22. The firm has a market cap of $3.12 billion, a price-to-earnings ratio of 33.21 and a beta of 1.11.

Balchem (NASDAQ:BCPC) last posted its quarterly earnings results on Friday, May 3rd. The basic materials company reported $0.73 earnings per share for the quarter, beating analysts’ consensus estimates of $0.69 by $0.04. Balchem had a return on equity of 14.11% and a net margin of 12.20%. The business had revenue of $157.00 million for the quarter, compared to analysts’ expectations of $165.57 million. During the same quarter in the prior year, the business earned $0.76 EPS. The firm’s revenue for the quarter was down 2.7% on a year-over-year basis. Analysts predict that Balchem Co. will post 2.97 EPS for the current year.

BCPC has been the subject of a number of research reports. HC Wainwright reissued a “buy” rating and set a $110.00 target price on shares of Balchem in a research note on Monday, May 6th. BidaskClub cut Balchem from a “buy” rating to a “hold” rating in a research note on Thursday, May 23rd. Zacks Investment Research downgraded Balchem from a “buy” rating to a “hold” rating in a research report on Wednesday, May 8th. Finally, Pivotal Research downgraded Balchem from a “buy” rating to a “hold” rating and set a $100.00 price target for the company. in a research report on Monday, May 6th. Five research analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. The company currently has a consensus rating of “Hold” and a consensus target price of $112.50.

About Balchem

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical, medical sterilization, and industrial markets in the United States and internationally. The company's Human Nutrition & Health segment supplies ingredients in the food and beverage industry.

Recommended Story: Net Income

Institutional Ownership by Quarter for Balchem (NASDAQ:BCPC)

Receive News & Ratings for Balchem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Balchem and related companies with MarketBeat.com's FREE daily email newsletter.